Drug

Antineoplaston AS 2-1 clinical trials

studies test it: 10
open now: 2
in phase 3: 2
first study started: 1996

Keep track of what changes. Save the antineoplaston AS 2-1 studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

How studies write it

Studies that test it under each name

Name

antineoplaston AS2-1: 6
Astugenal: 3
AS2-1: 3

Written with another drug

antineoplaston A10, antineoplaston AS2-1 (ANP): 1
Antineoplaston therapy (Atengenal + Astugenal)ANP: 1

Studies by the year they started

3 studies that test it; most in 1996 (2); 1 more planned to start later

Studies that test antineoplaston AS 2-1, by start year
Year	Studies
1996	2
2025	1

By phase

A phase 1/2 study counts in both.

Phase 2: 8
Phase 3: 2

What it is tested for

Each study’s main condition, where its own words name it.

Glioma: 1
Colonic Neoplasms: 1
Adenocarcinoma: 1
Prostatic Neoplasms: 1
Breast Neoplasms: 1
Carcinoma, Merkel Cell: 1
Lymphoma, Mantle-Cell: 1
Lymphoma: 1

Who runs them

Industry 0 · Other 10

Burzynski Research Institute (10)

Often tested with

Tested in the same studies.

Antineoplaston A10 (4)

Studies

Open first, then newest update. How each study uses antineoplaston AS 2-1 is read from its arms, and is right about nine times in ten.